News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
MonoSolRx LLC Sets IPO at 4 Mln Shares, $16-$18 Each
August 29, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Aug 29 (Reuters) - MonoSol Rx Inc. on Wednesday set its planned initial public offering at 4 million shares for an estimated price of $16 to $18 each.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Neurodegenerative diseases
Takeda Breaks Up With Denali, Dumps Dementia Drug
April 6, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
April 3, 2026
·
3 min read
·
Annalee Armstrong
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
April 1, 2026
·
1 min read
·
Annalee Armstrong